Parkside Financial Bank & Trust Iovance Biotherapeutics, Inc. Transaction History

Parkside Financial Bank & Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$6.38 - $18.33 $459 - $1,319	-72 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $792 - $1,222	64 Added 800.0%	72 $2,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $3,028 - $5,056	-183 Reduced 95.81%	8 $0
Q3 2021 Oct 29, 2021	BUY	$20.35 - $26.63 $1,017 - $1,331	50 Added 35.46%	191 $5,000
Q2 2021 Aug 06, 2021	BUY	$16.33 - $33.07 $2,253 - $4,563	138 Added 4600.0%	141 $4,000
Q3 2020 Nov 06, 2020	BUY	$27.75 - $36.3 $83 - $108	3 New	3 $0

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.17B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.